Results 121 to 130 of about 15,506 (210)

Narcolepsy as an immune-associated hypothalamic encephalopathy: orexin dysfunction and implications for precision sleep medicine. [PDF]

Front Psychiatry
Arias-Carrión O, Ortega-Robles E, Romano P, Pineda C.   +3 more
europepmc   +1 more source

Sensor-Based Assessment of Morning Prospective Memory in Narcolepsy Type 1: Evidence from Children and Adult Cohorts. [PDF]

Sensors (Basel)
Tonetti L, Giovagnoli S, Gnazzo M, Occhionero M, Pizza F, Plazzi G, Natale V.   +6 more
europepmc   +1 more source

Anti-Ma2 Encephalitis as a Treatable Cause of Narcolepsy Type 1: A Case Report. [PDF]

Am J Case Rep
Wang M, Zhang N, Bian Z, Li Y, Wang S.
europepmc   +1 more source

Practical Guidance for Initiation and Management of Patients on Once-Nightly Sodium Oxybate for Narcolepsy Treatment: Modified Delphi Panel Consensus Recommendations. [PDF]

Neurol Ther
Mulvany M, Wermter E, Lavender M, Merius H, Martin C, Burns A, Simmons J.   +6 more
europepmc   +1 more source

Dynamic Brain State Alterations in Narcolepsy: A Hidden Markov Model Approach to Thalamocortical Instability and Symptom-Specific Neural Correlates. [PDF]

Brain Behav
Li W, Jia L, Wang X, Zhao Y, Li Z, Geng Z.   +5 more
europepmc   +1 more source

An updated systematic review and meta-analysis of modafinil for excessive daytime sleepiness in narcolepsy. [PDF]

Sleep Med X
Mann GS, Ramakrishnan M, Pakkam ML, Sufiyan N, Kukadiya R, Girigosavi KB.   +5 more
europepmc   +1 more source

High-resolution sleep fragmentation assessment in narcolepsy type 1 and their non-narcoleptic siblings: a 5-s mini-epoch study. [PDF]

Sleep
Follin LF, Viste R, Vevelstad J, Langdalen K, Hansen BH, Grande RKB, Kaufmann T, Christensen JAE, Zahid AN, Viken MK, Juvodden HT, Knudsen-Heier S.   +11 more
europepmc   +1 more source

Dyskinesia following modafinil administration in a patient with autism spectrum disorder and narcolepsy: a case report. [PDF]

J Med Case Rep
Niijima K, Kume K, Murabayashi N, Wakai M.   +3 more
europepmc   +1 more source

Adenosine A₁ and A_2A Receptors in Sleep Disorders: Mechanisms and Therapeutic Implications. [PDF]

Biomol Ther (Seoul)
Jee HJ, Youn C, Lee H, Jung YS.
europepmc   +1 more source

Novel 3‑Heteroaryl Pyrrolidine and Piperidine Compounds as Orexin Receptor Agonists for Treating Sleep Disorders, namely, Narcolepsy and Hypersomnia. [PDF]

ACS Med Chem Lett
Sabnis RW.
europepmc   +1 more source